From the magazine

Letters: How ‘Nick’ could save the Tories

The Spectator
 iStock
EXPLORE THE ISSUE 14 June 2025
issue 14 June 2025

Dying wish

Sir: As a 99-year-old with, presently, no intention of requesting assistance to die, I am struck by the articles of Dan Hitchens and Tom Tugendhat (‘Bitter end’ and ‘Killing me softly’, 7 June), which base their strong opposition on the opinions of everyone other than the person supposed to be requesting such assistance. He or she, poor soul, is expected to just lie there and listen to whether they are to be allowed to have any opinion at all on the matter. It’s my life they are writing about. At present I have the ability to end it whenever I might wish. What Messers Hitchens and Tugendhat are arguing is that, if I change my mind, no one is to be allowed to help me at a moment of my choosing. That’s wrong.

Alan Hall

Westerham, Kent

Life lessons

Sir: In response to Tom Tugendhat, having seen a friend suffering with severe agitation because of uncontrolled pain, my concern is that there is a strong disincentive for medical practitioners to provide adequate pain control, as adequate doses can exceed the upper limit of the ‘normal’ recommended range, leaving the doctor liable to litigation.

My proposal is to introduce a form of advance instruction from patients: Pain-relief Over Prolongation Of Life (POPOL). Similar to the Do Not Resuscitate (DNR) for life-threatening medical emergency advance instructions at the front of the medical record, this would make it clear that the patient and relatives stipulate giving enough analgesia to control pain, despite the likelihood of it shortening life. It would have similar status to the DNR.

This could be relatively easily adopted and would provide a much less controversial way than ‘assisted dying’ of achieving what many people want – a pain-free death.

GIF Image

Disagree with half of it, enjoy reading all of it

TRY 3 MONTHS FOR $5
Our magazine articles are for subscribers only. Start your 3-month trial today for just $5 and subscribe to more than one view

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in